Navigation Links
Hospira Names Brian Meadows Supply Chain Chief
Date:4/27/2009

LAKE FOREST, Ill., April 27 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, announced today that Brian Meadows has been named corporate vice president, Supply Chain. In this capacity, he will be responsible for enterprise-wide supply chain operations including demand and supply planning; strategic sourcing and supplier management; procurement; materials and production planning; transportation management and distribution operations.

In addition, Meadows will lead the procurement effort within Project Fuel, Hospira's multi-phased initiative designed to identify and liberate resources across the organization to reduce complexity, improve efficiencies and optimize financial performance. The procurement effort will leverage Hospira's global scale to provide a sustainable advantage in the areas of productivity, cost, innovation and flexibility with the company's suppliers.

"Brian is a proven operations executive with leadership strengths in supply chain management and cost reduction," said Terrence C. Kearney, chief operating officer, Hospira. "Establishing Hospira's supply chain as a competitive advantage is a key strategic imperative, and we're excited to have Brian leading this effort."

Most recently, Meadows, 48, was senior vice president of supply chain management at Sprint-Nextel Corporation, where he led the integration of the supply chain operations of Sprint and Nextel Communications. Prior to Sprint, Meadows was the senior vice president of supply chain management at Nextel, where he centralized and built the supply chain organization. His supply chain operating experience is complemented by a consulting career in which he was a principal at A.T. Kearney and a partner at Deloitte Consulting.

Meadows earned his bachelor's degree from the University of Wisconsin-Madison in Civil and Environmental Engineering, and his master's of business management from the Kellogg School of Management at Northwestern University.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Biogenerics Will Save Billions, Says Hospira CEO
2. Hospiras Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
3. Hospira Expands Board of Directors
4. Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
5. Hospira Hosts Conference Call for Third-Quarter 2008 Earnings
6. StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
7. Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
8. Hospira Supports Newly Introduced Biogenerics Legislation
9. KGI Names Kerry Howell Vice President for Advancement
10. Vical Names Andrew de Guttadauro Vice President, Corporate Development
11. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  Northwell Health today ... advance of precision cancer research. ... largest health care provider, Northwell Health diagnoses and ... GmbH is a Germany -based ... therapies. Together they will greatly expand cancer biobanking ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... and NetDimensions, a global provider of learning and performance management systems for high-consequence ... mainland China market. , “In the life sciences industry, organizations must pay much ...
(Date:1/16/2017)... ... January 16, 2017 , ... Appellate Court of New ... the appeal filed by India-based Dishman Pharmaceutical & Chemical Ltd. company (DPCL) for ... one of its Dishman Group’s 100% wholly owned New Jersey-based subsidiary Dishman USA ...
(Date:1/14/2017)... ... January 14, 2017 , ... ... providing complete end-to-end genome assemblies to researchers around the globe. Long considered ... obstacle in answering a wide range of scientific questions. The announcement was ...
Breaking Biology Technology:
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... biometric sensor technology, today announced the launch of ... sensor systems, the highly-accurate biometric sensor modules that ... biometric technology, experience and expertise. The two new ... designed specifically for hearables, and Benchmark BW2.0, a ...
(Date:12/22/2016)... -- As part of its longstanding mission to improve genetic literacy ... released its latest children,s book, titled The One ... topics of inheritance and variation of traits that are part ... school classrooms in the US. The book ... Killoran , whose previous book with 23andMe, You ...
(Date:12/20/2016)... LONDON , Dec. 20, 2016 ... car sharing, rental and leasing is stoking significant ... of radio frequency technology, Bluetooth low energy (BLE), ... emerge as the next wave of wireless technologies ... vehicle access system to advanced access systems opens ...
Breaking Biology News(10 mins):